top of page

Designing the Next Generation of
Psycho-targeted Biotherapeutics

Artboard – 1_2x.png

3 Primary Breakthroughs for The Treatment of Mental Health Issues.

ADN
1_2x.png

IP Protected Bio synthetic pathway for candidate production

2_2x.png

Ability to Manufacture and conduct invitro & invivo efficacy testing and conduct human clinical trial

3_2x.png

Portfolio of psycho-targeted biotherapeutics

synopsis.png
Left side graphic_2x.png

Pioneering the design of psycho-targeted therapeutics for the improvement of mental and neurological health

Psybio has developed a portfolio of bio-medical chemistry development psycho-targeted compounds for the potential treatment for mental and neurological health.

Psybio Was Formed to Create Psycho-targeted Biotherapeutics

Dedicated Research and Development Laboratory

Miami University, Oxford, OH

Manufacturing Partners

Curia Global
Biose Industrie

Lawrence Berkley National Lab

Analyst
Coverage

Maxim Group

Noble Capital Markets

Pills_2x.png

World Class Team Of Experts

Over 50 Years of Combined Leadership in the Biotech Industry
Clinical Trial Design, Approval, Execution, and Analysis Expertise
Regulatory Pathway, Intellectual Property, and Manufacturing Skills

Bullet_2x.png
Bullet_2x.png
Bullet_2x.png
Send Us a Message

 

Investor Inquiries

bottom of page